These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
665 related items for PubMed ID: 23289476
1. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J. Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476 [Abstract] [Full Text] [Related]
2. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Yuan X, Zhang J, Li D, Mao Y, Mo F, Du W, Ma X. Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008 [Abstract] [Full Text] [Related]
3. Elevated CD163+/CD68+ Ratio at Tumor Invasive Front is Closely Associated with Aggressive Phenotype and Poor Prognosis in Colorectal Cancer. Yang C, Wei C, Wang S, Shi D, Zhang C, Lin X, Dou R, Xiong B. Int J Biol Sci; 2019 Oct; 15(5):984-998. PubMed ID: 31182919 [Abstract] [Full Text] [Related]
4. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma. Kim KJ, Wen XY, Yang HK, Kim WH, Kang GH. PLoS One; 2015 Oct; 10(12):e0144192. PubMed ID: 26714314 [Abstract] [Full Text] [Related]
5. High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Lan C, Huang X, Lin S, Huang H, Cai Q, Lu J, Liu J. Cell Tissue Res; 2013 May; 352(2):351-9. PubMed ID: 23397428 [Abstract] [Full Text] [Related]
6. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Lima L, Oliveira D, Tavares A, Amaro T, Cruz R, Oliveira MJ, Ferreira JA, Santos L. Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833 [Abstract] [Full Text] [Related]
7. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count. Li YL, Shi ZH, Wang X, Gu KS, Zhai ZM. BMC Cancer; 2019 Nov 06; 19(1):1049. PubMed ID: 31694577 [Abstract] [Full Text] [Related]
8. Detection of M2-macrophages in uveal melanoma and relation with survival. Bronkhorst IH, Ly LV, Jordanova ES, Vrolijk J, Versluis M, Luyten GP, Jager MJ. Invest Ophthalmol Vis Sci; 2011 Feb 03; 52(2):643-50. PubMed ID: 20811059 [Abstract] [Full Text] [Related]
9. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers. Pelekanou V, Villarroel-Espindola F, Schalper KA, Pusztai L, Rimm DL. Breast Cancer Res; 2018 Dec 17; 20(1):154. PubMed ID: 30558648 [Abstract] [Full Text] [Related]
10. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. Medrek C, Pontén F, Jirström K, Leandersson K. BMC Cancer; 2012 Jul 23; 12():306. PubMed ID: 22824040 [Abstract] [Full Text] [Related]
11. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival. Barros MH, Segges P, Vera-Lozada G, Hassan R, Niedobitek G. PLoS One; 2015 Jul 23; 10(5):e0124531. PubMed ID: 25978381 [Abstract] [Full Text] [Related]
12. High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Sugimura K, Miyata H, Tanaka K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y. J Surg Oncol; 2015 May 23; 111(6):752-9. PubMed ID: 25752960 [Abstract] [Full Text] [Related]
13. [Prognostic significance of tumor-associated macrophage infiltration in advanced epithelial ovarian carcinoma]. Wan T, Liu JH, Zheng LM, Cai MY, Ding T. Ai Zheng; 2009 Mar 23; 28(3):323-7. PubMed ID: 19619451 [Abstract] [Full Text] [Related]
14. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma. Salmi S, Siiskonen H, Sironen R, Tyynelä-Korhonen K, Hirschovits-Gerz B, Valkonen M, Auvinen P, Pasonen-Seppänen S. Melanoma Res; 2019 Jun 23; 29(3):237-247. PubMed ID: 30399061 [Abstract] [Full Text] [Related]
15. Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Troiano G, Caponio VCA, Adipietro I, Tepedino M, Santoro R, Laino L, Lo Russo L, Cirillo N, Lo Muzio L. Oral Oncol; 2019 Jun 23; 93():66-75. PubMed ID: 31109698 [Abstract] [Full Text] [Related]
16. The number of CD163 positive macrophages is associatedwith more advanced skin melanomas, microvessels density and patient prognosis. Foks M, Wągrowska-Danilewicz M, Danilewicz M, Bonczysta M, Olborski B, Stasikowska-Kanicka O. Pol J Pathol; 2019 Jun 23; 70(3):217-222. PubMed ID: 31820866 [Abstract] [Full Text] [Related]
17. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. Jackute J, Zemaitis M, Pranys D, Sitkauskiene B, Miliauskas S, Vaitkiene S, Sakalauskas R. BMC Immunol; 2018 Jan 24; 19(1):3. PubMed ID: 29361917 [Abstract] [Full Text] [Related]
18. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas. Lin MW, Yang CY, Kuo SW, Wu CT, Chang YL, Yang PC. Ann Surg Oncol; 2016 Sep 24; 23(9):3071-81. PubMed ID: 27150441 [Abstract] [Full Text] [Related]
19. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma. Klein JL, Nguyen TT, Bien-Willner GA, Chen L, Foyil KV, Bartlett NL, Duncavage EJ, Hassan A, Frater JL, Kreisel F. Am J Clin Pathol; 2014 Mar 24; 141(3):381-7. PubMed ID: 24515766 [Abstract] [Full Text] [Related]
20. An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Nam SJ, Go H, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK. Leuk Lymphoma; 2014 Nov 24; 55(11):2466-76. PubMed ID: 24397616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]